NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...

A Chinese pharmaceutical company expects to hire up to 500 employees for the first phase of its new campus in northern ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Shares of WuXi group companies jumped Monday after U.S. President-elect Trump promised to save TikTok and held a call with his counterpart in China, sparking tentative hopes that some areas of ...

WuXi AppTec sells US device testing sites to NAMSA, Notch Therapeutics cuts staff, and Neurizon's ALS drug NUZ-001 faces FDA clinical hold.

The companies have committed to working in close collaboration to ensure a smooth transition for employees and customers.

Texas A&M took on its fourth straight ranked opponent on Sunday evening in Norman. The Sooners dominated with a 77-62 win. Oklahoma started off red hot, after ...

The Lady Bees defended the hive from the Lady Lions, taking down No. 12 Franklin to remain undefeated in district play and pull into sole possession of ...

JPMorgan upgraded Wuxi Biologics (WXXWY) to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth and improved margins. Although the newsthat WuXi Bio ...

The year also saw weak demand for laboratory space and operated under the specter that Congress would ban the Chinese-owned biotech research and manufacturing firm WuXi AppTec. WuXi has a large ...

SHANGHAI, Dec. 30, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...